Skip to content

Preparation of treatment satisfaction tool on selected aspect of nursing to assess the treatment satisfaction of patients receiving chemotherapy and use of FACT G tool to assess quality of life of patients receiving chemotherapy among adult solid tumors at Tata Memorial Hospital

A prospective study to assess the treatment satisfaction on selected aspect of nursing and quality of life in patients receiving chemotherapy for adult solid tumor cancers at tertiary care centre

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/03/024008
Enrollment
300
Registered
2020-03-16
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D49-D49- Neoplasms of unspecified behavior

Interventions

None listed

Sponsors

Tata Memorial Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1)Age >18. 2)Patients who will be receiving 1st cycle of chemotherapy and day 8 after chemotherapy. 3)Patients who can understand English, Hindi, Marathi and Bengali.

Exclusion criteria

Exclusion criteria: 1)All paediatric patients. 2)Patients who are on antipsychotic drugs. 3)Patients who are not willing to participate.

Design outcomes

Primary

MeasureTime frame
To assess the treatment satisfaction in patients receiving chemotherapy for adult solid tumor cancers at tertiary care centreTimepoint: Data collection at two time points i.e. i. Patient receiving 1st cycle chemotherapy ii. Day 8 after chemotherapy

Secondary

MeasureTime frame
-To assess the quality of life in patients receiving chemotherapy for adult solid tumor cancers -To compare the level of treatment satisfaction and quality of life of patients with two time points of chemotherapy administration -To compare the association between the treatment satisfaction of patients and socio demographic dataTimepoint: Data collection at two time points i.e. i. Patient receiving 1st cycle chemotherapy ii. Day 8 after chemotherapy

Countries

India

Contacts

Public ContactMs Rongsenlila

Tata Memorial Hospital

prathepa_jagadish@rediffmail.com9869220441

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026